Verb Biotics
Americas
Boulder
,
United States
Scaleup
FOUNDED
2021
HEADCOUNT
FUNDING
Series A
Keywords:
probiotics, postbiotics, microbiome, AI/ML, HTP_screening, bacteria
BUSINESS
Develops specialized probiotics and postbiotics for human and companion animal health targeting stress, sleep, immunity, and gut health. Verb Biotics is a B2B ingredient company developing clinically validated probiotic, postbiotic, and synbiotic ingredients for food, beverage, dietary supplement, and companion animal brands. In June 2023, Verb acquired YSOPIA Bioscience's strain and IP portfolio. Products include a GABA-producing probiotic for mood and sleep support and a Keystone Postbiotic for digestive and immune health.
BIOTECH INVOLVEMENT
Core; applies biotechnology and microbiome science to engineer bioactive probiotic strains and postbiotics. Verb Biotics uses AI and high-throughput screening to search millions of microbial strains to identify candidates that produce specific bioactive metabolites at therapeutic levels. The company combines strain engineering, fermentation for biomass and metabolite production, and formulation science (including stacking of strains with botanicals and substrates). The approach is metabolite-centric rather than strain-centric, prioritizing the functional output of fermentation over traditional CFU-based probiotic metrics.
TECHNOLOGY PLATFORM
probiotic strain engineering; microbiome modulation
PRIMARY PRODUCTS
LP815 GABA Probiotic; Keystone Postbiotic